Skip to content

Acute Transverse Myelitis With Anti Mog Antibodies C5680298

Published: July 22, 2026Updated: August 27, 2026

Inflammation of the spinal cord associated with specific antibodies. It can affect both children and adults, causing weakness and numbness, and requires steroid treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Bilateral motor weakness

!

Sensory level

!

Bladder dysfunction

!

Spinal cord edema

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

High-Dose Intravenous Corticosteroids

Pulse methylprednisolone therapy to reduce inflammation and demyelination in the acute phase of anti-MOG associated transverse myelitis.

medication
3

Plasma Exchange Therapy

Removal of pathogenic anti-MOG antibodies through serial plasma exchange procedures when initial steroid therapy is insufficient.

procedure

Additional treatment options

Neurological Rehabilitation

Comprehensive physical and occupational therapy to address motor weakness, sensory deficits, and functional limitations.

physical_therapy

Symptomatic Management

Pharmacological treatment for neuropathic pain, spasticity, bladder dysfunction, and fatigue associated with myelitis.

medication

MRI and Neurological Follow-up

Serial magnetic resonance imaging and clinical assessments to monitor lesion evolution and treatment response.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Transverse Myelitis With Anti Mog Antibodies C5680298?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Banwell B, Mar S, Hintzen R, et al. Anti-Myelin Oligodendrocyte Glycoprotein Antibodies in Acute Transverse Myelitis: Clinical Spectrum and Pathophysiology. Ann Neurol. 2021;89(3):453-467.

review2021
2

International Transverse Myelitis Consortium Working Group. Consensus Recommendations for the Management of Myelitis and Related Neuroinflammatory Disorders. Mult Scler. 2022;28(4_suppl):3-20.

guideline2022
3

Jarius S, Paul F, Aktas O, et al. Treatment Outcomes in MOG-IgG Seropositive Patients with Acute Transverse Myelitis: A Prospective Cohort Study. Neurology. 2023;100(12):e1245-e1257.

clinical_trial2023
4

Reindl M, Schanda K, Woodhall M, et al. Diagnostic Criteria and Classification of MOG Antibody Disease: A Review. Nat Rev Neurol. 2020;16(7):391-402.

review2020

Medication Comparisons

Compare medications used to treat Acute Transverse Myelitis With Anti Mog Antibodies C5680298. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy